Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study

Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study have?

Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study has 40 citations in the OpenAlex counts ScholarIQ stores.

When was Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study published?

Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study has 2018 year in the ScholarIQ index.

What is the open-access status of Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study?

Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study has gold oa status in the ScholarIQ index.

What is the DOI of Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study?

The DOI for Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study is on the source record.

What is the PMID of Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study?

The PMID for Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study is on the source record.

What is the OpenAlex record for Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study?

The OpenAlex for Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study is on the source record.